Westlake Chemical Partners WLKP · NYSE
$21.22 +0.43% (+$0.09)
Summary
73 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 67% a year over the last 3 years.
- It earns 30 USD a year on every 100 USD of invested capital.
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 33 USD is left as free cash.
What to watch
- Revenue fell by 9.9% a year over the last 3 years.
- It pays out more in dividends than it earns: 115% of profit.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.0 USD for 1 USD of yearly profit. Over the last five years it was 10.7 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 3.8% a year over 5 years. Over the last 3 years it fell by 9.9% a year. Earnings per share grew by 67% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 69 USD
- Sales and administration 2.4 USD
- Taxes and other 24 USD
- Net profit 4.7 USD
Net profit, industry median (Chemicals) 4.6 USD
Out of every 100 USD of revenue, 4.7 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 8.91%
- Paid out of profit
- 115%
You receive $1.89 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 3
- Hold 7
- Sell 0
Today's price within the analysts' price targets
The average target of $26 is 23% above today's price. 30% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2020By product
- Product and Service, Other 100%
By region
The company reports no revenue by region.
Product and Service, Other brings in 100% of revenue.
Segments in detail